Filing Details
- Accession Number:
- 0001645470-19-000050
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-27 11:53:05
- Reporting Period:
- 2019-09-24
- Accepted Time:
- 2019-09-27 11:53:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1645470 | Brian Alan Collier | 6320 Canoga Avenue 15Th Floor Woodland Hills CA 91367 | Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-09-24 | 100 | $0.01 | 25,330,397 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-24 | 100 | $0.01 | 25,330,497 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-25 | 100 | $0.01 | 25,330,597 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-25 | 200 | $0.01 | 25,330,797 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-25 | 200 | $0.01 | 25,330,997 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |